David has more than 25 years’ management experience in Fortune 500 and entrepreneurial companies. His expertise spans a broad spectrum with specialization in technology integration and commercialization. 

As co-founder of Milestones − a business strategies and science marketing firm − David has for the last seven years collaborated to build a diverse portfolio of more than 60 client relationships in drug development, diagnostics, and bioinformatics. He works with executives to develop business strategies, from technology assessment through market research, product development and product positioning. With his business partner, David writes news and commentary for business and life sciences publications.

David provides “dual-use” product assessment and commercialization counsel a number of military research portfolios whose research organizations and companies have received funding through Congressionally directed appropriations. The tri-service technology portfolios include the U.S. Army's Medical Research and Materiel Command (MRMC) as a founding member of the Product Assessment and Commercialization Team (PACT) program, the Telemedicine and Advanced Technology Research Center (TATRC) and the Congressionally Directed Medical Research Programs (CDMRP) located at Ft. Detrick, MD. Additionally he provides product development counsel to the Office of the USAF Surgeon General | Directorate of Modernization (SGR) and the Naval Research Lab.

For the decade prior to Milestones, David participated in the formation and executive management of eight life science companies resulting in value creation. He consulted to a wide range of healthcare sector companies including: therapeutics; point-of-care diagnostics; microbial feed additives; biochemicals (e.g., lipids, proteins, and polysaccharides); and image processing software for medical and scientific applications. He’s provided due diligence and technology evaluation in support of fundraising and other strategic initiatives for the venture capital industry.

David initiated his career at Abbott Diagnostics and through a decade managed sales and operations for the African Business Unit and hematology market development as the company evolved exponentially, from a $100 million to a $1 billion division. Expertise included immunodiagnostics and analytical systems. He was awarded “Salesman of the Year” at the end of his first full year at Abbott Diagnostics in 1976. Based on his performance at Abbott, David was recruited to Syntex (Syva) to manage the marketing for the core international business of therapeutic drug monitoring.

He has served on the Board of Directors for Response Biomedical and Novate Technologies. David has co-authored more than 20 business articles and is frequently tapped by business writers for insights into the growth and development of the life sciences and biotechnology industry. He attended university on both football and academic scholarships and graduated the University of Wisconsin - Madison with a B.S. in Zoology. 4.2.2005

CONTACT INFO:

Milestones - the critical thinking company
P.O. Box 22423
Seattle, WA 98122

206.444.0022 T
206.770.7276 F
davegab@thinkmilestones.com

BACK TO OUR WORK ►